TG Therapeutics logo

TG Therapeutics

Brand · Biotechnology Research

2.2

Company overview

TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) and from several regulatory agencies outside of the U.S for its therapy as a treatment for relapsing multiple sclerosis. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn.
Founded in 2011
Morrisville, North Carolina, USA
501 employees (46 in marketing)
www.tgtherapeutics.com
18% recommend to a friend
22% positive business outlook

Salaries

Help build salary transparency at TG Therapeutics

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

1 open now

Headcount trend

Company growth over the last 12 months

Headcount +22.2% year over year

Funding

Total funding

$455M

Last raise

$250M

Post IPO Debt, 2 years ago

Funding history

Aug 2024

Post IPO Debt TG Therapeutics · $250M

Jan 2022

Post IPO Debt TG Therapeutics · $70M

Dec 2019

Post IPO Equity TG Therapeutics · $50M

Feb 2019

Post IPO Debt TG Therapeutics · $60M

Feb 2012

Post IPO Equity TG Therapeutics · $25M

Audience

Monthly website visitors
29.4K
Month over month+95.5%
Quarter over quarter+77.2%
Top sourceDirect (48.4%)
Ad budget per month$0.0
Average search rank56.8
Traffic source mix
Direct
48.4%
Search
36.1%
Referral
8.2%
Social
5.7%
Paid referral
1.4%

LinkedIn followers

Follower count and growth

Total followers

46.4K

12-mo growth

+45.3%

Monthly growth

+4%

News

Links

www.tgtherapeutics.comLinkedInCrunchbaseX (Twitter)
Glassdoor